Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation
Tze‐Fan Chao(National Yang Ming Chiao Tung University), Shih‐Ann Chen(National Yang Ming Chiao Tung University), Jo‐Nan Liao(L-3 Communications (United States)), Ta‐Chuan Tuan(National Yang Ming Chiao Tung University), Gregory Y.H. Lip(Medical University of Białystok), Fa‐Po Chung(L-3 Communications (United States)), Li‐Wei Lo(National Yang Ming Chiao Tung University), Yenn‐Jiang Lin(National Yang Ming Chiao Tung University), Tzeng‐Ji Chen(Taipei Veterans General Hospital), Chia‐Jen Liu(National Yang Ming Chiao Tung University), Yu‐Feng Hu(Albert Einstein College of Medicine), Shih‐Lin Chang(National Yang Ming Chiao Tung University)
Cited by 221
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
|European Heart Journal|2016|2.5k
2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines
|European Journal of Heart Failure|2016|1.8k
Antithrombotic Therapy for Atrial Fibrillation
|CHEST Journal|2012|919